Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells

European Journal of Immunology

Volumn 41, Issue 10, 2011, Pages 2871-2882

  Singh, Vibhuti ^a,b   Mueller, Ulrike ^a   Freyschmidt Paul, Pia ^b   Zöller, Margot ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Autoimmunity; Delayed type hypersensitivity; Myeloid derived suppressor cells; Signal transduction

Indexed keywords

AUTOANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE LCK; SQUARIC ACID DIBUTYL ESTER; T LYMPHOCYTE RECEPTOR;

ALOPECIA AREATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME ACTIVATION; FLOW CYTOMETRY; HAIR GROWTH; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALOPECIA AREATA; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-CD8 RATIO; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLOBUTANES; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MITOCHONDRIA; MYELOID CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053137436     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141696     Document Type: Article

References (53)

1. Kalish, R. S. and Gilhar, A., Alopecia areata: autoimmunity--the evidence is compelling. J. Investig. Dermatol. Symp. Proc. 2003. 8: 164-167.
2. Ito, T., Meyer, K. C., Ito, N. and Paus, R., Immune privilege and the skin. Curr. Dir. Autoimmun. 2008. 10: 27-52.
3. King, L. E., Jr., McElwee, K. J. and Sundberg, J. P., Alopecia areata. Curr. Dir. Autoimmun. 2008. 10: 280-312.
4. Petukhova, L., Duvic, M., Hordinsky, M., Norris, D., Price, V., Shimomura, Y., Kim, H., et al., Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010. 466: 113-117.
5. Tobin, D. J., Gardner, S. H., Lindsey, N. J., Hoffmann, R., Happle, R. and Freyschmidt-Paul, P., Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata. Eur. J. Dermatol. 2002. 12: 327-334.
6. Herbst, V., Zöller, M., Kissling, S., Wenzel, E., Stutz, N. and Freyschmidt-Paul, P., Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur. J. Dermatol. 2006. 16: 537-542.
7. Happle, R. and Echternacht, K., Induction of hair growth in alopecia areata with D.N.C.B. Lancet 1977. 2: 1002-1003.
8. McElwee, K. J., Freyschmidt-Paul, P., Hoffmann, R., Kissling, S., Hummel, S., Vitacolonna, M. and Zöller, M., Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J. Invest. Dermatol. 2005. 124: 947-957.
9. Freyschmidt-Paul, P., Sundberg, J. P., Happle, R., McElwee, K. J., Metz, S., Boggess, D. and Hoffmann, R., Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J. Invest. Dermatol. 1999. 113: 61-68.
10. Happle, R., Klein, H. M. and Macher, E., Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch. Dermatol. Res. 1986. 278: 214-218.
11. Hoffmann, R., Wenzel, E., Huth, A., van der Steen, P., Schäufele, M., Henninger, H. P. and Happle, R., Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J. Invest. Dermatol. 1994. 103: 530-533.
12. Balansky, R., D'Agostini, F., Ganchev, G., Izzotti, A., Di Marco, B., Lubet, R. A., Zanesi, N. et al., Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine. Proc. Natl. Acad. Sci. USA 2006. 103: 7823-7828.
13. Zöller, M., Gupta, P., Marhaba, R., Vitacolonna, M. and Freyschmidt-Paul, P., Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases. J. Leukoc. Biol. 2007. 82: 57-71.
14. Marhaba, R., Vitacolonna, M., Hildebrand, D., Baniyash, M., Freyschmidt-Paul, P. and Zöller, M., The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 2007. 179: 5071-5081.
15. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
16. Ilkovitch, D., Role of immune-regulatory cells in skin pathology. J. Leukoc. Biol. 2011. 89: 41-49.
17. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S. and Bronte, V., Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010. 22: 238-244.
18. Nicholson, L. B., Raveney, B. J. and Munder, M., Monocyte dependent regulation of autoimmune inflammation. Curr. Mol. Med. 2009. 9: 23-29.
19. Vaknin, I., Blinder, L., Wang, L., Gazit, R., Shapira, E., Genina, O., Pines, M., et al., A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression. Blood 2008. 111: 1437-1447.
20. Zhang, Y., Liu, Q., Zhang, M., Yu, Y., Liu, X. and Cao, X., Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J. Immunol. 2009. 182: 3801-3808.
21. Vinuesa, C. G., Rigby, R. J. and Yu, D., Logic and extent of miRNA-mediated control of autoimmune gene expression. Int. Rev. Immunol. 2009. 28: 112-138.
22. Holzer, A. M., Kaplan, L. L. and Levis, W. R., Haptens as drugs: contact allergens are powerful topical immunomodulators. J. Drugs Dermatol. 2006. 5: 410-416.
23. Ribechini, E., Greifenberg, V., Sandwick, S. and Lutz, M. B., Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. 2010. 199: 273-281.
24. Zöller, M., McElwee, K. J., Vitacolonna, M. and Hoffmann, R., Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J. Autoimmun. 2004. 23: 241-256.
25. Nefedova, Y., Fishman, M., Sherman, S., Wang, X., Beg, A. A. and Gabrilovich, D. I., Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res. 2007. 67: 11021-11028.
26. Freyschmidt-Paul, P., McElwee, K. J., Hoffmann, R., Sundberg, J. P., Vitacolonna, M., Kissling, S. and Zöller, M., Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br. J. Dermatol. 2006. 155: 515-521.
27. Buckner, J. H., Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 2010. 10: 849-859.
28. Zöller, M., McElwee, K. J., Engel, P. and Hoffmann, R., Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J. Invest. Dermatol. 2002. 118: 983-992.
29. Gupta, S. and Gollapudi, S., Molecular mechanisms of TNF-alpha-induced apoptosis in naïve and memory T cell subsets. Autoimmun. Rev. 2006. 5: 264-268.
30. Zöller, M., Freyschmidt-Paul, P., Vitacolonna, M., McElwee, K. J., Hummel, S. and Hoffmann, R., Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. Clin. Exp. Immunol. 2004. 135: 398-408.
31. Gupta, P., Freyschmidt-Paul, P., Vitacolonna, M., Kiessling, S., Hummel, S., Hildebrand, D., Marhaba, R. and Zöller, M., A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. J. Invest. Dermatol. 2006. 126: 1559-1573.
32. Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., ikarsky, E. et al., TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J. Immunol. 2006. 177: 4763-4772.
33. Gilhar, A., Paus, R. and Kalish, R. S., Lymphocytes, neuropeptides, and genes involved in alopecia areata. J. Clin. Invest. 2007. 117: 2019-2027.
34. Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K. and Khoury, S. J., CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 5228-5237.
35. Haverkamp, J. M., Crist, S. A., Elzey, B. D., Cimen, C. and Ratliff, T. L., In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 2011. 41: 749-759.
36. Moliné-Velázquez, V., Cuervo, H., Vila-Del Sol, V., Ortega, M. C., Clemente, D. and de Castro, F., Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol. 2011. Doi: 10.1111/j.1750-3639.2011.00495.x.
37. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M.P., Basso, G. et al., Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD+ T cells. J. Clin. Invest. 2006. 116: 2777-2790.
38. Hegde, V. L., Nagarkatti, P. S. and Nagarkatti, M., Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 2011. 6: e18281.
39. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Krüger, C., Bachmann, O., Westendorf, A. M., Buer, J., et al., Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008. 135: 871-881.
40. Sun, J., Silva, K. A., McElwee, K. J., King, L. E., Jr. and Sundberg, J. P., The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp. Dermatol. 2008. 17: 793-805.
41. Sinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A. and Ostrand-Rosenberg, S., Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 2011. 117: 5381-5390.
42. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M. and Chen, S. H., Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 1123-1131.
43. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. and Van Ginderachter, J. A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4444.
44. Beutler, B. and Poltorak, A., Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. Eur. Cytokine Netw. 2000. 11: 143-152.
45. Martin, S. F., Dudda, J. C., Bachtanian, E., Lembo, A., Liller, S., Dürr, C., Heimesaat, M. M., et al., Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 2008. 205: 2151-2162.
46. Tantivejkul, K., Loberg, R. D., Mawocha, S. C., Day, L. L., John, L. S., Pienta, B. A., Rubin, M. A. and Pienta, K. J., PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism. J. Cell. Biochem. 2005. 96: 641-652.
47. Van Herreweghe, F., Festjens, N., Declercq, W. and Vandenabeele, P., Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell. Mol. Life Sci. 2010. 67: 1567-1579.
48. Strasser, A., Jost, P. J. and Nagata, S., The many roles of FAS receptor signaling in the immune system. Immunity 2009. 30: 180-192.
49. Chipuk, J. E. and Green, D. R., How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell. Biol. 2008. 18: 157-164.
50. Ross, K., Rudel, T. and Kozjak-Pavlovic, V., TOM-independent complex formation of Bax and Bak in mammalian mitochondria during TNFalpha-induced apoptosis. Cell Death Differ. 2009. 16: 697-707.
51. Lovell, J. F., Billen, L. P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B. and Andrews, D. W., Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008. 135: 1074-1084.
52. Li, J., Li, Y., Qin, D., von Harsdorf, R. and Li, P., Mitochondrial fission leads to Smac/DIABLO release quenched by ARC. Apoptosis 2010. 15: 1187-1196.
53. McElwee, K. J., Boggess, D., King, L. E., Jr. and Sundberg, J. P., Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J. Invest. Dermatol. 1998. 111: 797-803.